NL-OMON29762尚未招募4 期
Cerebrovascular effects of galantamine treatment in patients with Alzheimer's disease. - Cerebrovascular effects of galantamine
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •meeting DSM IV-R criteria for dementia
- •meeting NINCDS-ADRDA criteria for probable AD
- •clinical dementia rating scale (CDR) of 0.5 to 1.5
排除标准
- •contra-indication for or unwilling to receive treatment with cholinesterase inhibitors
- •major cerebrovascular disease (stroke)
研究者
相似试验
已完成
不适用
The effects of galantamine administration on brain network topology in patients with Alzheimer's disease (AD): A possible new biomarker for pharmacotherapy of ADmild to moderate Alzhiemer's diseaseJPRN-UMIN000018749atinal Center of Neurology and Psychiatry9
已完成
不适用
The effects of galantamine on brain network topology in patients with Alzheimer's diseasemild to moderate Alzhiemer's diseaseJPRN-jRCTs031180337Hanakawa Takashi9
已完成
3 期
Efficacy of galantamine on cognitive performanceObsessive-compulsive disorderSchizophreniaIRCT20200207046404N1Sanandaj University of Medical Sciences75
已完成
不适用
Effect of agomelatine on cerebral activity measured by functional magnetic resonance imaging (MRI) in patients with major depressive disorder in comparison to healthy volunteersISRCTN53505070Institut de Recherches Internationales Servier (France)44
进行中（未招募）
不适用
The ACER-study - examining the effects of galantamine on gait.EUCTR2011-006011-62-NLSlotervaart Hospital